We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Snl3.0
Snail Mucin Research
Mostly mechanism / observationalHigh safety
5 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Snail Mucin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2013–2024 with a typical study size of 40 participants.
Based on 5 studies · 1 RCT · 65 total participants
Confidence
Low
By outcome
Wound & ulcer healing
Too few graded studies2 studies
Inflammation
Too few graded studies1 study
Skin healthImproved hydration and smoothness from a glycoprotein/HA-rich film (cosmetic, not a health outcome) · 4-12 weeks · Modest reduction in fine-line appearance in one small split-face trial (cosmetic; evidence is thin) · 8-12 weeks
Too few graded studies1 study
Active research area
2 studies in the last 5 years
201320182024
1RCTn=25 · very small study2013
Periocular rhytides on the active ingredient side showed significant improvement after 12 weeks (P=.03) and improved texture to a greater degree than placebo at 8 and 12 weeks, as well as 2 weeks after discontinuing the product (14 weeks).
Double-blind, randomized, split-face design (n=25): an 8% SCA emulsion plus 40% SCA serum on one side vs placebo on the other for 12 weeks
Periocular wrinkles on the SCA side improved significantly versus placebo (P=.03), with greater texture improvement at 8 and 12 weeks
Well tolerated; benefit was limited to periocular/fine rhytides — subjects reported no significant difference in overall skin quality
2Review2020
Further research studies are warranted to elucidate any biological or therapeutic mechanisms of action of these ingredients, which may translate into clinical practice.
Nguyen JK, Masub N, Jagdeo J. · J Cosmet Dermatol (2020)
Narrative review of Korean cosmeceutical bioactives including snail mucin, surveying lab, animal, and clinical studies
Reports snail mucin shows bioactivities with potential for skin rejuvenation, photoprotection, and wound healing
Explicitly concludes further research is warranted before clinical translation — the evidence base is still emerging
The formulation studied included moisturizing, emollient, film-forming, and retinoid ingredients in addition to the mollusk egg extract to produce the clinical improvement.
Draelos ZD. · J Drugs Dermatol (2017)
Single-arm, 12-week open-label study (n=40, ages 40-70) of a mollusk-egg anti-aging cream twice daily
Investigator ratings improved at week 12: 53% less roughness (P<0.001), 26% more brightness (P<0.001), 39% higher elasticity (P<0.001)
Confounded: the formulation also contained emollient, film-forming, and retinoid ingredients, with no placebo control — the effect can't be attributed to the snail extract
5In Vitro2024
HASC extract exhibited superior inhibitory activity compared to HAS against collagenase and tyrosinase enzymes (IC50 = 8.4 ± 1.19 vs. 15.3 ± 1.12 μg/mL) and (IC50 = 30.1 ± 0.91 vs. 35 ± 1.3 μg/mL).
Alkhadhrh M, Issa R, Al-Halaseh LK, Alnsour L, Alsarayreh A, Al Qaisi Y, Matalqah SM, Aladwan S. · J Cosmet Dermatol (2024)
In-vitro characterization of Helix aspersa snail slime; identified phenolics, flavonoids, ascorbic acid, and fatty acids
Slime extracts showed antioxidant activity and dose-dependent inhibition of collagenase and tyrosinase — the enzymatic basis for anti-aging/brightening claims
Purely biochemical assays; no skin, cell, animal, or human outcomes — speaks only to plausible mechanism